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in the venous plasma (p < 0.01). Exercise until exhaus-
tion increased plasma S1P and sphinganine-1-phosphate 
(SA1P) concentration (p < 0.05), whereas moderate-inten-
sity exercise elevated only SA1P (p < 0.001). Although 
knee extension increased muscle S1P content (p < 0.05), it 
was not released but taken up across the leg during exer-
cise. However, sphingosine was released from both work-
ing and resting leg at the highest workload (p < 0.05).
Conclusions Plasma S1P concentration is elevated only by 
high-intensity exercise which results, at least in part, from 
increased availability of sphingosine released by skeletal 
muscle. In addition, exercise markedly affects S1P dynam-
ics across the leg. We speculate that S1P may play an impor-
tant role in adaptation of skeletal muscle to exercise.
Keywords Ceramides · Dihydrosphingosine · Lipids · 
Red blood cells · Sphingolipids · Thrombocytes
Abbreviations
ANOVA  Analysis of variance
PBS  Phosphate-buffered saline
S1P  Sphingosine-1-phosphate
S1PR  Sphingosine-1-phosphate receptor
SA1P  Sphinganine-1-phosphate
SPHK  Sphingosine kinase
VO2 max  Peak oxygen uptake
Wmax  Maximal work capacity
Introduction
Although sphingoid base-1-phosphates represent only 
a minor portion of the cellular sphingolipid pool, they 
are potent bioactive lipids. In mammals, sphingoid 
base-1-phosphates mainly include two compounds: 
Abstract 
Purpose Sphingosine-1-phosphate (S1P) regulates cardiovas-
cular function and plays an important role in muscle biology. 
We have previously reported that cycling exercise increased 
plasma S1P. Here, we investigated the effect of exercise dura-
tion and intensity on plasma and skeletal muscle S1P levels.
Methods In the first experiment, 13 male athletes per-
formed a 60-min exercise at 65 % of VO2max and a graded 
exercise until exhaustion on a rowing ergometer. Samples of 
the venous blood were taken, and plasma, erythrocytes and 
platelets were isolated. In the second experiment, ten male 
moderately active subjects performed three consecutive peri-
ods of one-leg knee extension exercise (at 25, 55 and 85 % 
of the maximal workload). Muscle biopsies and blood sam-
ples from the radial artery and femoral veins were taken.
Results Under basal conditions, S1P was released from 
the leg, as its concentration was lower in the arterial than 
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sphingosine-1-phosphate (S1P) and sphinganine-1-phos-
phate (SA1P). Both S1P and SA1P are thought to be pro-
duced exclusively by phosphorylation of free sphingoid 
bases (sphingosine and sphinganine, respectively) catalyzed 
by sphingosine kinase (SPHK) (Liu et al. 2012). Substrates 
for sphingoid base-1-phosphates production can be pro-
vided through de novo synthesis, ceramide/dihydrocera-
mide deacylation, or from extracellular sources (Gault et al. 
2010). Degradation of sphingoid base-1-phosphates occurs 
either through the irreversible action of sphingosine-1-phos-
phate lyase to produce palmitaldehyde and phosphoethan-
olamine, or through dephosphorylation to free sphingoid 
bases by sphingosine-1-phosphate phosphatases and non-
specific lipid phosphatases (Liu et al. 2012) (Fig. 1).
S1P plays a dual role in cellular signaling, acting either 
as an intracellular messenger or by binding to a fam-
ily of five plasma membrane G protein-coupled receptors 
(S1PRs) that are ubiquitously expressed in tissues (Strub 
et al. 2010). It should be noted that S1PRs are also acti-
vated by SA1P; however, the biological activity of this 
compound is poorly characterized (Tamama et al. 2001). 
S1P and SA1P are normal constituents found in human 
plasma in relatively high concentrations that are above the 
EC50 for S1PRs (Yatomi 2008). Studies conducted during 
the last few years revealed important physiological function 
of blood S1P. Pappu et al. (2007) found that high plasma 
concentration of this sphingolipid is required for lympho-
cyte egress from lymphoid organs to blood. In addition, 
mice that selectively lack S1P in plasma are characterized 
by increased basal and inflammation-induced vascular leak 
indicating impaired endothelial barrier function (Camerer 
et al. 2009). Plasma S1P is also involved in the regula-
tion of vascular tone and cardiac function (Alewijnse et al. 
2004), as well as bone homeostasis (Ishii and Kikuta 2013).
We have previously reported that exercise increased 
sphingoid base-1-phosphate levels in rat skeletal and cardiac 
muscle (Baranowski et al. 2008; Blachnio-Zabielska et al. 
2008), which prompted us to examine in the subsequent 
study whether physical effort induces similar effects also 
in blood. We found that 60-min cycling exercise at 70 % 
of VO2 max increased plasma levels of S1P and SA1P in 
untrained but not in endurance-trained subjects (Baranowski 
et al. 2011). On the other hand, we also showed that 48-hour 
ultramarathon run markedly reduced concentration of these 
sphingoid base-1-phosphates (Baranowski et al. 2014). 
These contradictory findings prompted us to further exam-
ine this issue in the present study by investigating the effect 
of exercise of various duration and intensity. Plasma S1P is 
implicated in several diseases, including cancer, myocar-
dial infarction, osteoporosis and atherosclerosis (Strub et al. 
2010; Hla and Brinkmann 2011). Therefore, clarification of 
the direction of exercise-induced change in plasma S1P con-
centration may have potential clinical relevance.
There is some evidence suggesting that skeletal mus-
cle may contribute to alterations in plasma sphingoid base-
1-phosphate levels associated with exercise. In our previous 
studies, exercise was found to induce accumulation of sphin-
gosine and sphinganine in rat muscles in a time-dependent 
manner (Dobrzyn and Gorski 2002), and it should be noted 
that muscle tissue is able to release free sphingoid bases into 
the circulation (Cavalli et al. 2002). We hypothesized that 
blood during its passage through the working skeletal mus-
cle is enriched with sphingosine and sphinganine, which are 
subsequently used by blood cells to produce S1P and SA1P, 
and that this effect depends on exercise intensity and/or dura-
tion. In the present study, we aimed to test this hypothesis by 
using two types of physical effort: rowing that engages all 
major muscle groups in the body, and one-leg knee extension 
exercise model that relies on work of isolated muscle group 
and lowers the strain on the cardiovascular system.
Materials and methods
The investigation conforms with the principles outlined in 
the Declaration of Helsinki and was approved by the Ethical 
Fig. 1  Schematic representation of metabolism of free sphingoid 
bases and their 1-phosphates. LPP lipid phosphate phosphatase, S1P 
sphingosine-1-phosphate, SA1P sphinganine-1-phosphate
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Committee for Human Studies of the Józef Piłsudski Uni-
versity of Physical Education and by the Ethics Commit-
tee for Medical Research in Copenhagen. All subjects gave 
their informed consent prior to their inclusion in the study.
Exercise on the rowing ergometer
Thirteen healthy male athletes were recruited from the stu-
dents of the Faculty of Physical Education and Sport at the 
Józef Piłsudski University of Physical Education. All sub-
jects were non-smokers and were not taking any medicine 
at the time of enrollment. Ten of the subjects were runners, 
two were mixed martial arts competitors, and one was a 
cross-country skier (average experience of 5.8 ± 0.9 years). 
Characteristics of the subjects are given in Table 1. Dur-
ing the 4 weeks preceding the experiment the subjects per-
formed eight 1-hour training sessions to familiarize with the 
rowing ergometer (Concept 2, model C, Morrisville, USA) 
and the proper technique of rowing. The participants were 
studied on two separate days over a 1-week period. On the 
first day, they were subjected to a graded exercise on the 
rowing ergometer starting at 100 W for 3 min followed by 
increments of 40 W every 3 min until exhaustion. Peak oxy-
gen uptake (VO2 max) was determined during this session 
using an online system (Start 2000, MES, Cracow, Poland). 
Blood samples were drawn before and immediately after the 
exercise through a catheter inserted into an antecubital vein. 
The average time until exhaustion was 18.7 ± 0.6 min.
Seven days later the subjects performed a 60-min exer-
cise on the same rowing ergometer at a workload estimated 
to elicit a load of 65 % of individual VO2 max. The mean 
heart rate at 30 and 60 min of the exercise was 157 ± 4 and 
157 ± 5, respectively. This time blood samples were taken 
just before the exercise, after 30 and 60 min of rowing, and 
following 30 min and 24 h of rest. Subjects were instructed 
to abstain from alcohol use during the 2 days preceding 
each visit in the laboratory.
One-leg knee extension exercise
Ten healthy males were recruited for the study. Character-
istics of the subjects are given in Table 1. This study and 
the basal data of the included subjects have been used for 
a prior publication with a different focus (Stallknecht et al. 
2007). Prior to the experiment, subjects were accustomed 
to exercise on the knee extension ergometer and maxi-
mal work capacity (Wmax) was determined for each leg as 
described by Andersen and Saltin (1985). At least 5 days 
before the first experimental day, subjects performed a 
VO2 max test on a cycle ergometer using a standard progres-
sive exercise test. Subjects were instructed to abstain from 
alcohol and tobacco use on the days preceding each visit 
in the laboratory. On the day of the experiment, after an 
initial short rest, a catheter (Arterial Cannula with FloS-
witch, Becton–Dickinson, UK) was inserted in the brachial 
or radial artery for blood sampling. Furthermore, catheters 
were placed in both femoral veins under local anesthesia 
by an aseptic technique, and the tips were advanced to 
~2 cm below the inguinal ligament in the antegrade direc-
tion. The catheters were kept patent by intermittent flushing 
with sterile sodium citrate throughout the procedure. The 
protocol consisted of an initial 15-min resting period and 
three consecutive periods of one-leg knee extension exer-
cise (the kicking rate was 60 times per minute). Subjects 
first exercised with one leg for 30 min at 25 % of Wmax and 
after a 30-min rest subjects exercised with the other leg 
for 120 min at 55 % of Wmax with a short break (~5 min, 
required to perform muscle biopsy) after the first 30 min. 
After a 30-min rest, the subjects again exercised with the 
first leg for 30 min but now at 85 % of Wmax. Selection of 
the leg eligible for low/high or moderate intensity was done 
by randomized stratification, such that dominant and non-
dominant legs were similarly represented. Both during the 
resting and the exercise periods, subjects were sitting in a 
chair with the torso strapped to the back of the chair. Sub-
jects had free access to water throughout the experiment. 
Prior to each exercise bout and during exercise, blood flow 
was measured by the Doppler technique as previously 
described (Radegran and Saltin 1998).
Before and after each exercise period (and after 30 min 
of exercise at 55 % of Wmax), a muscle biopsy was obtained 
from vastus lateralis in the working leg under local anal-
gesia (2–3 ml lidocaine, 20 mg/ml) using the Bergström 
technique applied with suction. The incisions were made 
approximately 12–18 cm above the knee and two samples 
were obtained from each incision, but in the opposite direc-
tion, distal–proximal to that of the first biopsy. The biopsies 
were frozen in liquid nitrogen within 10–15 s of sampling 
and were stored at −80 °C until further analysis.
Blood was sampled at the same time points as the mus-
cle biopsies were taken. Prior to each blood sample (15–
20 s), a cuff placed under the knee was inflated to suprasys-
tolic pressure to minimize contribution from the lower leg. 
Blood was sampled into iced tubes and immediately centri-
fuged to separate plasma.
Table 1  Participant characteristics
The results are mean ± SEM
One-leg knee exten-
sion exercise (n = 10)
Exercise on the rowing 
ergometer (n = 13)
Age (years) 26 ± 2 22 ± 0.4
Height (cm) 183 ± 2 180 ± 2
BMI (kg/m2) 24.5 ± 0.8 22.6 ± 0.6
VO2 max (ml/kg/min) 49 ± 2 56 ± 1
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Uptake and release of sphingolipids over the leg were 
calculated from arterial and femoral venous differences 
multiplied by plasma flow, according to the Fick principle.
Blood fractionation
Immediately after sampling into 4 ml EDTA tubes, blood 
was centrifuged at 300×g for 10 min at 4 °C, and the plate-
let-rich plasma was transferred to a fresh plastic tube. The 
leukocyte-rich buffy coat was thoroughly removed. Sepa-
rated erythrocytes were suspended in precooled phosphate-
buffered saline (PBS), centrifuged at 800×g for 10 min at 
4 °C and the upper layer as well as the remaining buffy coat 
was discarded. Red blood cells were then resuspended in 
PBS and flash frozen in liquid nitrogen. Platelet-rich plasma 
was centrifuged at 1,000×g for 10 min at 4 °C to separate 
platelets. Supernatant was then transferred to a fresh plas-
tic tube and recentrifuged at 5,000×g for 10 min at 4 °C 
to obtain platelet-free plasma. Isolated thrombocytes were 
washed with platelet wash buffer (5 mM KH2PO4, 5 mM 
Na2HPO4, 0.1 M NaCl, 1 % glucose, 0.63 % sodium cit-
rate, pH 6.6), suspended in PBS, and flash frozen in liquid 
nitrogen. All samples were stored at −80 °C until analysis.
Hemoglobin concentration in erythrocyte suspensions 
was determined colorimetrically using Drabkin’s reagent 
kit (Sigma, Schnelldorf, Germany). Protein concentration 
in platelet samples was measured with the BCA protein 
assay kit (Sigma). Bovine serum albumin (fatty acid free, 
Sigma) was used as a standard.
Blood and muscle sphingolipid analysis
Standards utilizing 18C-sphingoid bases: sphingosine 
d18:1, sphinganine d18:0, sphingosine-1-phosphate d18:1, 
sphinganine-1-phosphate d18:0, d18:1/14:0-Cer—ceramide 
containing myristic acid (C14:0-Cer), d18:1/16:0-Cer—
ceramide containing palmitic acid (C16:0-Cer), d18:1/17:0-
Cer—ceramide containing margaric acid (C17:0-Cer, inter-
nal standard for ceramides), d18:1/18:0-Cer–ceramide 
containing stearic acid (C18:0-Cer), d18:1/18:1-Cer–cera-
mide containing oleic acid (C18:1-Cer), d18:1/20:0-Cer–
ceramide containing arachidic acid (C20:0-Cer), d18:1/
C22:0-Cer–ceramide containing behenic acid (C22:0-
Cer), d18:1/24:0-Cer–ceramide containing lignoceric 
acid (C24:0-Cer), d18:1/24:1-Cer–ceramide containing 
nervonic acid (C24:1-Cer) as well as standards utilizing 
17C-sphingoid bases: sphingosine (d17:1-Sph, internal 
standard for sphingosine and sphinganine), sphingosine-
1-phosphate (d17:1-S1P, internal standard for S1P and 
SA1P), were purchased from Avanti Polar Lipids (Alabas-
ter, AL). The HPLC-grade methanol and water as well as 
formic acid, ammonium formate and ethanol were obtained 
from Sigma–Aldrich (St. Louis, MO).
Sphingolipid content was determined using the method 
described by Blachnio-Zabielska et al. (2012) with minor 
modifications. In brief, sphingolipids were extracted from 
~20 mg of tissue, 100 μl of plasma and erythrocyte suspen-
sion, and 150 μl of platelet suspension by the use of the 
extraction mixture composed of isopropanol:water:ethyl 
acetate (35:5:60; v:v:v). Quantitative measurement of 
sphingolipids (sphingosine, sphinganine, S1P, SA1P, 
C14:0-Cer, C16:0-Cer, C18:1-Cer, C18:0-Cer, C20:0-Cer, 
C22:0-Cer, C24:1-Cer, C24:0-Cer) was made using an 
Agilent 6460 Triple quadrupole mass spectrometer. Sphin-
golipids were analyzed using positive ion electrospray ioni-
zation source with selected reaction monitoring. The chro-
matographic separation was performed using an Agilent 
1290 Infinity Ultra High Performance Liquid Chromatog-
raphy system. The analytical column was a reverse-phase 
Zorbax SB-C8 column 2.1 × 150 mm, 1.8 μm (Agilent, 
Santa Clara, CA).
Chromatographic separation was conducted in binary 
gradient using 2 mM ammonium formate, 0.15 % formic 
acid in methanol as Solvent A and 1.5 mM ammonium for-
mate, 0.1 % formic acid in water as Solvent B at the flow 
rate of 0.4 ml/min. C17-sphingosine, C17-S1P and C17:0-
ceramide were used as an internal standards.
Statistical analysis
All data are presented as mean ± SEM. Statistical compari-
sons were made using one-way repeated measures ANOVA 
followed by Newman–Keuls post hoc test or by Student’s 
t test for paired samples. p < 0.05 was considered statisti-
cally significant.
Results
Exercise on the rowing ergometer
After 60 min of the exercise at 65 % of individual VO2 
max plasma, SA1P level was increased by 40 % (p < 0.01). 
This effect persisted for at least 30 min after cessation of 
the exercise (p < 0.001). However, 24 h later, plasma SA1P 
concentration was back to the baseline level. Exercise until 
exhaustion increased plasma sphingosine, sphinganine, 
S1P and SA1P concentration (by 27, 17, 12 and 19 %, 
respectively, p < 0.05) (Fig. 2). There were no significant 
changes in the total ceramide concentration or individual 
ceramide species levels during or after either exercise (see 
supplementary Table 1).
The level of sphinganine in erythrocytes was increased by 
39 % after 60 min of rowing at 65 % of individual VO2 max 
(p < 0.01). A similar trend was observed for SA1P; however, 
the difference reached statistical significance only 30 min 
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post-exercise (p < 0.05). Nevertheless, 24 h after cessation 
of the exercise, the content of both sphinganine and SA1P 
in erythrocytes decreased back to the initial value. Exercise 
until exhaustion did not affect erythrocyte level of free sphin-
goid bases or their 1-phosphates (Fig. 3a). Platelet sphin-
golipid levels were not significantly altered by either exer-
cise (Fig. 3b). Neither individual ceramide species nor total 
ceramide level in erythrocytes and platelets was affected by 
exercise (see supplementary Tables 2 and 3).
One-leg knee extension exercise
Muscle sphingosine and sphinganine content tended 
to increase after each exercise session, but the increase 
reached statistical significance only for sphinganine after 
exercise at the highest workload (31 % increase, p < 0.02). 
On the other hand, muscle S1P level was markedly elevated 
by exercise at 55 and 85 % of Wmax (p < 0.05). In the for-
mer case, the content of S1P was increased both after 30 
and 120 min of the exercise (by 45 and 82 %, respectively) 
(Fig. 4). The level of total ceramide or individual ceramide 
species in skeletal muscle was not significantly affected by 
exercise at either workload (see supplementary Table 4).
Basal S1P concentration in the venous plasma was 30 % 
higher than in the artery (213 ± 11 and 164 ± 9 pmol/ml, 
respectively, p < 0.01). Exercise tended to increase arterial 
S1P concentration. However, the difference reached statisti-
cal significance only in the case of exercise at 25 % of Wmax 
and after 30 min of exercise at 55 % of Wmax (p < 0.03). On 
the other hand, S1P concentration in the venous plasma taken 
from the working leg (but not from the resting one) was 
decreased after exercise at 25 % of Wmax (p < 0.02, Fig. 5). 
The concentrations of total ceramide or individual ceramide 
species in the arterial as well as in the venous plasma were not 
affected by either exercise (see supplementary Tables 5–7).
The rate of uptake/release of sphingolipids over the leg 
was calculated by multiplying the arterio-venous differ-
ences by plasma flow. Under basal conditions, S1P was 
released across both legs (Fig. 6). Surprisingly, after exer-
cise at 55 and 85 % of Wmax, a marked uptake of S1P across 
the working leg was observed (p < 0.04 and p < 0.001, 
respectively). A similar, albeit much weaker trend could be 
seen also in the resting leg (p < 0.002, Fig. 6). It should 
be noted that after 30 min of rest separating each exer-
cise, S1P was neither released nor taken up across either 
leg. Exercise at 85 % of Wmax (but not at lower workloads) 
induced sphingosine release across both resting and work-
ing leg (p < 0.002 and p < 0.03, respectively). In the case 
of sphinganine and SA1P (Fig. 6), as well as total ceramide 
or individual ceramide species (see supplementary Tables 8 
and 9), neither release nor uptake could be clearly observed 
under basal conditions or during exercise.
Discussion
There is some evidence indicating that free sphingoid 
bases may affect muscle excitation–contraction coupling. 
Fig. 2  Effect of exercise on a 
rowing ergometer on sphin-
golipid concentration in the 
plasma. Subjects performed 
60-min exercise at 65 % of indi-
vidual VO2 max (white bars) and 
graded exercise until exhaustion 
(black bars) on two separate 
days. Blood samples were taken 
from the antecubital vein at 
indicated time points (n = 13). 
The results are mean ± SEM. 
*p < 0.05 vs. the value before 
the respective exercise. S1P 
sphingosine-1-phosphate, SA1P 
sphinganine-1-phosphate
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Sabbadini et al. (1992) showed that sphingosine acts 
directly on the sarcoplasmic reticulum ryanodine recep-
tor to inhibit calcium release in isolated rabbit muscle fib-
ers. A similar, albeit weaker, effect is exerted by sphinga-
nine (McDonough et al. 1994). It was also postulated that 
exercise-induced sphingosine production contributes to the 
development of muscle fatigue (Sabbadini et al. 1999). In 
our previous reports, marked accumulation of sphingosine 
and sphinganine was observed in rat skeletal muscles in 
response to electrical stimulation or exercise on a treadmill 
Fig. 3  Effect of exercise on a 
rowing ergometer on eryth-
rocyte (a) and platelet (b) 
sphingolipid content. Subjects 
performed 60-min exercise  
at 65 % of individual VO2 max  
(white bars) and graded exercise 
until exhaustion (black bars) 
on two separate days. Blood 
samples were taken from the 
antecubital vein at indicated 
time points (n = 13). The 
results are mean ± SEM. 
*p < 0.05 vs. the value before 
the respective exercise. S1P 
sphingosine-1-phosphate, SA1P 
sphinganine-1-phosphate
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(Dobrzyn and Gorski 2002; Blachnio-Zabielska et al. 
2008). However, in the present study, knee extension exer-
cise induced only minor changes in muscle content of these 
sphingoid bases. Our results indicate that sphingosine and 
sphinganine are unlikely to play a significant role in skel-
etal muscle fatigue or regulation of muscle performance 
in humans. This is also supported by the fact that muscle 
and plasma-free sphingoid base levels did not correlate 
with VO2 max regardless of the exercise intensity or duration 
(data not shown).
On the other hand, muscle S1P content was increased 
by knee extension exercise in proportion to its duration 
and intensity. This observation is in line with the results of 
our previous animal experiment (Blachnio-Zabielska et al. 
2008). It was also recently reported that resistance train-
ing increases plasma S1P concentration and muscle S1PRs 
expression in rats (Banitalebi et al. 2013). There is a grow-
ing body of evidence from animal studies that S1P plays 
a significant role in skeletal muscle biology. Extracellular 
S1P was found to activate muscle satellite cells, stimu-
late myoblast differentiation, promote muscle repair, and 
exert a trophic effect on skeletal muscle. In addition, it was 
shown to affect the excitation–contraction coupling and 
delay muscle fatigue (reviewed in Donati et al. 2013). Tak-
ing together, our finding that exercise increases S1P level 
in both muscle and plasma suggests that this sphingolipid 
may play an important role in acute and/or long-term 
adaptation of skeletal muscle to exercise in humans. This 
is also supported by the fact that longer and more intense 
exercise, that is more likely to induce muscle fatigue, tran-
sient microdamage or hypertrophic response, was associ-
ated with greater increase in S1P level. However, further 
studies using genetic or pharmacological tools to manipu-
late S1P level in plasma and skeletal muscle are required 
to elucidate the role of S1P in exercise physiology. Mutant 
mice engineered to selectively lack S1P in plasma represent 
a perfect model for this purpose (Camerer et al. 2009).
We have previously found that prolonged, moderate-
intensity exercise did not affect plasma sphingolipid levels 
in endurance-trained athletes (Baranowski et al. 2011). This 
is in contrast to the present study where increased plasma 
SA1P concentration was observed in trained subjects dur-
ing and after exercise at 65 % of individual VO2 max. Dura-
tion and intensity of the exercise as well as subjects’ char-
acteristics in these two studies are very similar. The only 
significant difference is that in the present report exercise 
was performed on a rowing ergometer, whereas in the pre-
vious one cycle ergometer was used. Cycling involves pre-
dominantly hip extensors, knee extensors and ankle plan-
tar flexors (Ericson 1986), whereas rowing engages most 
of the principal muscle groups of both upper and lower 
body (Secher 1993). In consequence, a much larger frac-
tion of the total muscle mass is recruited during rowing 
when compared to cycling exercise (∼30 kg vs. ∼15 kg in 
a 70 kg male) (Secher 1993). The fact that exercise engag-
ing more muscle groups induced stronger effect on plasma 
SA1P level suggests that skeletal muscle contributed to this 
effect.
Red blood cells are considered to be an important source 
of plasma sphingoid base-1-phosphates since, in contrast to 
thrombocytes, they were shown to release S1P and SA1P spon-
taneously without any stimulation (Hanel et al. 2007). Inter-
estingly, the increase in plasma SA1P concentration induced 
by exercise at 65 % of individual VO2 max was associated with 
elevated sphinganine and SA1P content in erythrocytes. It is, 
therefore, most likely that the above-mentioned increase in 
plasma SA1P concentration resulted from enhanced synthesis 
and release of this sphingoid base-1-phosphate by red blood 
Fig. 4  Effect of one-leg knee extension exercise on sphingolipid con-
tent in skeletal muscle. Subjects performed three consecutive periods 
of exercise separated by 30 min of rest. First subjects exercised with 
one leg for 30 min at 25 % of maximal workload (Wmax), then with 
the other leg for 120 min at 55 % of Wmax, and finally again with the 
first leg for 30 min at 85 % of Wmax. The biopsies of vastus lateralis 
muscle from the working leg were taken at indicated time points 
(n = 10). The results are mean ± SEM. *p < 0.05 vs. the value before 
the respective exercise. S1P sphingosine-1-phosphate
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cells. However, the source of sphinganine that accumulated 
in erythrocytes remains obscure. Although we have observed 
a moderate increase in muscle sphinganine level after knee 
extension exercise at 85 % of Wmax, we did not find any evi-
dence that it was released to the circulation.
Interestingly, graded exercise until exhaustion increased 
plasma concentration of both S1P and SA1P. This obser-
vation indicates that S1P level in the plasma is elevated 
only by very high-intensity exercise. The above effect 
was associated with increased plasma sphingosine and 
Fig. 5  Effect of one-leg knee extension exercise on sphingolipid con-
centration in the plasma. Subjects performed three consecutive peri-
ods of exercise separated by 30 min of rest. First subjects exercised 
with one leg for 30 min at 25 % of maximal workload (Wmax), then 
with the other leg for 120 min at 55 % of Wmax, and finally again with 
the first leg for 30 min at 85 % of Wmax. Blood samples were taken 
from the radial artery as well as from both femoral veins at indicated 
time points (n = 10). The results are mean ± SEM. *p < 0.05 vs. the 
value before the respective exercise. S1P sphingosine-1-phosphate, 
SA1P sphinganine-1-phosphate
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sphinganine concentration. This implies that elevation of 
the level of sphingoid base-1-phosphates might result from 
an increased availability of substrates required for their 
synthesis. Nevertheless, sphingolipid levels in erythrocytes 
and platelets were not affected by graded exercise until 
exhaustion which suggests that blood cells did not con-
tribute to the effect observed in the plasma. Recent studies 
identified vascular endothelium and liver as other impor-
tant contributors of plasma S1P (Venkataraman et al. 2008; 
Kurano et al. 2013). We speculate that graded exercise until 
exhaustion might have increased the rate of sphingoid base-
1-phosphates production by these sources. It should be 
noted, however, that in the knee extension exercise experi-
ment S1P and SA1P were not released across the leg at any 
workload (including the 30-minute rest period separating 
each exercise) which indicates that skeletal muscle did not 
directly contribute to elevated levels of sphingoid base-
1-phosphates in plasma observed after exercise on a row-
ing ergometer. Nevertheless, we found that knee extension 
exercise at the highest workload induced sphingosine 
release across the leg suggesting that during intense work 
skeletal muscle may provide the substrate for increased 
S1P synthesis in other parts of the circulation. Interestingly, 
this phenomenon was observed in both working and rest-
ing leg suggesting that sphingosine release was not a direct 
consequence of muscle contractile activity but rather an 
effect of systemic changes related to the exercise.
Interestingly, in our study, basal S1P level was consid-
erably lower in the arterial compared to the femoral vein 
plasma. This observation strongly indicates that S1P is 
released to skeletal muscle circulation at rest, most likely 
by the vascular endothelium. Surprisingly, knee exten-
sion exercise induced a drastic change in S1P metabolism. 
After exercise at the medium and high workload S1P was 
no longer released but taken up across the working leg. 
Interestingly, SA1P metabolism in muscle was not simi-
larly affected, which provides an explanation why plasma 
level of this sphingoid base-1-phosphate is more likely to 
Fig. 6  Effect of one-leg knee extension exercise on the rate of sphin-
golipid uptake (positive values) or release (negative values) across 
the leg. Subjects performed three consecutive periods of exercise 
separated by 30 min of rest. First subjects exercised with one leg for 
30 min at 25 % of maximal workload (Wmax), then with the other 
leg for 120 min at 55 % of Wmax, and finally again with the first leg 
for 30 min at 85 % of Wmax. Blood samples were taken from the 
radial artery as well as from both femoral veins at indicated time 
points (n = 10). Uptake and release of sphingolipids over the leg 
were calculated from arterial and femoral venous differences multi-
plied by plasma flow, according to the Fick principle. The results are 
mean ± SEM. *p < 0.05 vs. the value before the respective exercise. 
S1P sphingosine-1-phosphate, SA1P sphinganine-1-phosphate
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increase in response to exercise. It was reported that vas-
cular endothelium is capable of not only secreting, but also 
degrading extracellular S1P. Intravenously administered 
C17–S1P is quickly eliminated from the plasma in mice 
(Salous et al. 2013), and in vitro experiments showed that 
extracellular S1P is rapidly degraded by human vascular 
endothelial cells via the action of lipid phosphate phos-
phatase expressed on the plasma membrane (Aoki et al. 
2005; Zhao et al. 2007). Our results suggest that exercise 
alters the balance between S1P release and degradation in 
muscle vascular endothelium.
The major limitation of our study is that the training 
sessions preceding the experiment could possibly induce a 
training effect in athletes not accustomed to rowing. How-
ever, we believe that this effect (if any) was modest, since 
these sessions were of low intensity and the subjects were 
already highly endurance trained. The training sessions 
were necessary as preliminary tests showed that subjects 
who are not accustomed to rowing need to be taught a 
proper technique to be able to complete 1-hour exercise on 
a rowing ergometer.
Conclusions
In summary, we found that under basal conditions S1P was 
released across the leg as the concentration of the com-
pound was lower in the arterial compared to the femoral 
vein plasma. Exercise until exhaustion increased plasma 
concentration of S1P and SA1P, whereas moderate-inten-
sity exercise elevated only SA1P level. Although knee 
extension exercise markedly increased muscle S1P con-
tent, sphingoid base-1-phosphates were not released but 
taken up across the leg during the exercise. It should be 
noted, however, that at the highest workload, sphingosine 
was released from both working and resting leg. We con-
clude that muscle S1P content is increased in proportion to 
exercise duration and intensity, whereas plasma S1P level 
is elevated only by very high-intensity exercise. The latter 
effect results, at least in part, from increased availability of 
sphingosine released by skeletal muscle. In addition, exer-
cise markedly affects S1P dynamics across the leg that is 
manifested by a transition from release to uptake. We spec-
ulate that S1P may play an important role in adaptation of 
human skeletal muscle to exercise.
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